共 50 条
- [1] Dolutegravir for second-line antiretroviral therapy LANCET INFECTIOUS DISEASES, 2019, 19 (03): : 218 - 219
- [3] Use of Dolutegravir for Antiretroviral Therapy for Women of Childbearing Age JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 2019, 48 (06): : 664 - 673
- [4] Hyperglycemia After Dolutegravir-Based Antiretroviral Therapy INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2021, 14 : 503 - 507
- [6] Dolutegravir for second-line antiretroviral therapy: the beat goes on LANCET GLOBAL HEALTH, 2024, 12 (02): : E183 - E184